Composition
- Active ingredients
- FULVESTRANT 250MG/5ML (50MG/ML)
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- FULVESTRANT 250MG/5ML (50MG/ML) · SolutionANDA209714-001 · Prescription
- FULVESTRANT 250MG/5ML (50MG/ML) · SolutionANDA208811-001 · Discontinued
- FULVESTRANT 250MG/5ML (50MG/ML) · SolutionNDA210326-001 · Prescription
- FULVESTRANT 250MG/5ML (50MG/ML) · SolutionANDA207754-001 · Prescription
- FULVESTRANT 250MG/5ML (50MG/ML) · SolutionANDA205871-001 · Prescription
- FULVESTRANT 250MG/5ML (50MG/ML) · SolutionANDA210044-001 · Prescription
- FULVESTRANT 250MG/5ML (50MG/ML) · SolutionANDA214682-001 · Prescription
- FULVESTRANT 250MG/5ML (50MG/ML) · SolutionANDA215169-001 · Discontinued
- FULVESTRANT 250MG/5ML (50MG/ML) · SolutionANDA215234-001 · Prescription
- FULVESTRANT 250MG/5ML (50MG/ML) · SolutionANDA215077-001 · Prescription
- FULVESTRANT 250MG/5ML (50MG/ML) · SolutionANDA205935-001 · Prescription
- FULVESTRANT 250MG/5ML (50MG/ML) · SolutionANDA209246-001 · Prescription
At a glance
- Brand name
- Fulvestrant
- Route
- Intramuscular
- Dosage form
- Solution
- Applicant
- Apotex
- Status
- Discontinued
- FDA approval
- 11 Jun 2021
- Application
- ANDA211730-001